# Bristol Myers Squibb Co: Form 8-K, filed May 9, 2024

- Company: [Bristol Myers Squibb Co](/companies/bmy.md) (CIK 14272)
- Form: 8-K
- Filed: 2024-05-09
- Accepted by EDGAR: May 9, 2024, 16:53 ET
- Period: 2024-05-07
- Accession: 0001140361-24-025213
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/14272/000114036124025213/ef20028830_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/14272/000114036124025213/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/14272/000114036124025213/ef20028830_8k.htm

Filed May 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-025213. Last ingested by Listed: Nov 6, 2026, 17:19 ET. No prices; not investment advice.